An evidence-based clinical practice...

An evidence-based clinical practice guideline (1) to inform physicians upon the management of uncomplicated acute otitis media (AOM) among children ages brace months through 12 years is now available. It was exhibited by the multidisciplinary Subcommittee forward Management of Acute Otitis Media, which was compos of representatives from the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and other relevant professional organizations. A summary of this clinical practice guideline appears in this issue of American Family Physician. (2)

Using a methodology similar to that used for the newly come guideline on the management of otitis media with effusion, (3) this AOM guideline is based forward the best available published data as summarized in the Agency for Healthcare Research and Quality report onward AOM (4) and literature subsequently published [i]or[/i] part of to the other September 2003. Evidence-based statements contained in the AOM guideline (1) go after AAP definitions, reflecting both the quality of evidence and the balance of benefit and harm. (5)

To highlight the fundamental note points, the guideline1 offers recommendations for accurate diagnosis, assessment, and treatment of pain, and the use of an observation option among selecteded patients, with interval reassessment.

* The diagnosis of AOM requires that the clinician confirm a history of acute attack identify signs of middle ear effusion, and evaluate for the appearance of signs and symptoms of middle ear inflammation. [Recommendation] The stage of diagnostic certainty, which should be discussed with the child's caregiver, is important because of its impact onward management strategies.

* The management of AOM should include an assessment of pain. If pain is quick in emergencies the clinician should recommend treatment to shape pain. [Strong recommendation] Because episodes of AOM commonly are associated with varying horizontals of discomfort, management of pain should be addressed.

* Observation without the use of antibacterial agents in a child with uncomplicated AOM is an option for rareed children based on diagnostic certainty, age, illness severity, and assurance of follow-up [Option] This "observation option" should be limited to otherwise healthy children six month to brace years of age with nonsevere illness at presentation and an uncertain diagnosis, and to children sum of two units years of age and older without bitter symptoms at presentation or with an uncertain diagnosis; access to follow-up care also should be ensured

This observation option relies forward clinical judgment and provides an opportunity for the patient to improve without antibacterial treatment. chiefly cases of AOM resolve, with 61 percent of children having decreased symptoms after 24 hours whether they receive placebo or antibacterial agents; by dint of seven days, about 75 percent of children have resolution of symptoms. (6) A meta-analysis (4) showed that there was a 12 percent reduction in the clinical failure rate within pair to seven days of diagnosis when ampicillin or amoxicillin was prescribed, compared with an initial use of placebo or observation (number exigencyed to treat, 8).

In 1990 observation was fortunately implemented in the Netherlands and has been jointly promot since 2002 by means of the New York State Department of Health and the just discovered York Region Otitis Project Committee. (78)

* If a decision is made to treat with an antibacterial agent, the clinician should prescribe amoxicillin for principally children. [Recommendation] The justification to use amoxicillin as first-line therapy in most numerous patients with AOM relates to its general effectiveness when used in sufficient dosages (80 to 90 mg through kg per day). The optimal duration of therapy is uncertain, and clinical sagacity is advised.

* Patients who fail to suit to the initial management option within 48 to 72 hours warrant reassessment to confirm AOM and bar other causes of illness. If AOM is confirmed in the patient initially managed with observation, the clinician should begin antibacterial therapy. If the patient initially was managed with an antibacterial agent(s), the clinician should change the antibacterial agent(s). [Recommendation]

* Clinicians should encourage the prevention of AOM by the and of reduction of risk factors. [Recommendation] Risk factor reduction includes promoting the use of pneumococcal conjugate and influenza vaccines.

The guideline made no recommendation regarding the use of complementary and alternative medicine in the management of AOM because of the lack of evidence documenting efficacy. In addition, the guideline identifies multiple research issues for primary care researchers relating to the diagnosis and management of AOM.

Care providers delineate an important ally to engage regarding monitoring and follow-up of children managed with the observation option. It should be noted, however, that these guidelines are not appropriate for all practice settings, and a certain number of may view these guidelines as controversial. These joint AOM guidelines provide valuable support for efforts to integrate evidence into clinical practice while potentially decreasing the unnecessary use of antibiotics.